Funded by the NIH HEAL Initiative®
This study will 1) test strategies to improve OUD pharmacotherapy treatment retention and to improve outcomes among patients who have been successfully stabilized on OUD medications and want to stop medication; and 2) identify predictors of successful outcome and develop a stage model of relapse risk.
Principal Investigator(s)
Edward V. Nunes, Jr., M.D.
1051 Riverside Drive
Unit 51, Room 3717
New York, NY 10032
United States
John Rotrosen, M.D.
One Park Avenue, 8th Floor
New York, NY 10016
United States
Roger D. Weiss, M.D.
115 Mill Street
Belmont, MA 02478
United States